Opportunities lie in providing training for companies to modernize their stability testing programs, ensuring compliance with updated ICH and global guidelines. This is crucial for avoiding delays and ...
The draft guidance ICH Q10 for pharmaceutical quality systems is part of the ongoing move to a science- and risk-based approach in manufacturing. The pharmaceutical industry's efforts to implement ...
Experts have recommended ICH Q10 PQS (International Council for Harmonisation - Pharmaceutical Quality System) guidelines on pharma quality systems for effective implementation of revised Schedule M ...
E22 guideline should incorporate caregiver feedback, according to responses submitted by industry groups and manufacturers to ...
Analytical characterization is vital for product quality, manufacturing control, and regulatory compliance in biopharmaceutical development. ICH Q6B outlines structural characterization requirements, ...
The final ICH E6 (R3) Good Clinical Practice (GCP) Guidelines were published on 6 th January 2025, updating the framework for clinical trials to reflect modern trial designs, technology, and data ...
Impact, challenges and the importance of ensuring readiness with ICH E2B (R3) EudraVigilance. While the EMA has done much to improve the EudraVigilance (EV) system, there have been some technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results